Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 | P41145 | 6/20 | 0.59 |
| ▸ | BACE1 | P56817 | 7/20 | 0.52 |
| ▸ | BACE2 | Q9Y5Z0 | 2/20 | 0.52 |
| ▸ | CTSD | P07339 | 1/20 | 0.52 |
| ▸ | NPY1R | P25929 | 1/20 | 0.51 |
| ▸ | NPY2R | P49146 | 1/20 | 0.51 |
| ▸ | NPY4R | P50391 | 1/20 | 0.51 |
| ▸ | GNPAT | O15228 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30851228 | 0.96 | OPRK1 (0.55) | OPRK1BACE1BACE2CTSDNPY1R | |
| SCHEMBL30051484 | 0.96 | OPRK1 (0.55) | OPRK1BACE1BACE2CTSDNPY1R | |
| SCHEMBL30397627 | 0.91 | OPRK1 (0.59) | OPRK1BACE1BACE2CTSDNPY1R | |
| SCHEMBL30957128 | 0.91 | OPRK1 (0.68) | OPRK1NPY1RNPY2RNPY4RGNPAT | |
| SCHEMBL30957126 | 0.90 | OPRK1 (0.69) | OPRK1NPY1RNPY2RNPY4RGNPAT | |
| SCHEMBL30957125 | 0.90 | OPRK1 (0.69) | OPRK1NPY1RNPY2RNPY4RGNPAT | |
| SCHEMBL30957130 | 0.90 | OPRK1 (0.69) | OPRK1NPY1RNPY2RNPY4RGNPAT | |
| SCHEMBL30957134 | 0.90 | OPRK1 (0.69) | OPRK1NPY1RNPY2RNPY4RGNPAT | |
| SCHEMBL30957133 | 0.90 | OPRK1 (0.69) | OPRK1NPY1RNPY2RNPY4RGNPAT | |
| SCHEMBL30957135 | 0.90 | OPRK1 (0.69) | OPRK1NPY1RNPY2RNPY4RGNPAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240117354-A1 | COMPOSITIONS AND METHODS FOR MODULATING EXPRESSION OF GENES | VERSAMEB AG (CH) | 2024-04-11 | — | — | US | disclosed |